ストックスクリーナーアプリを入手
2.21
20.28%
-0.60
前日終値:
$2.81
開ける：
$2.07
24時間の取引高:
270.12K
Relative Volume:
0.04
時価総額：
$404.77K
収益：
$75,000
当期純損益:
$-42.41M
株価収益率:
-0.0123
EPS:
-179.8206
ネットキャッシュフロー:
$-18.47M
1週間 パフォーマンス:
+1,623%
1か月 パフォーマンス:
+659.32%
6か月 パフォーマンス:
-69.52%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$2.00
$2.2774
1週間の範囲:
$0.0801
$3.01
52週間の値動き範囲:
$0.0801
$166.50
Profusa Inc Stock (PFSA) Company Profile
Compare PFSA vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
2.1714 | 523.81K | 75,000 | -42.41M | -18.47M | -179.82 |
ABT
Abbott Laboratories
|
95.24 | 166.94B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
328.56 | 126.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
82.53 | 107.31B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.71 | 67.33B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
93.89 | 54.60B | 6.30B | 1.07B | 1.09B | 1.8406 |
Profusa Inc (PFSA) 最新ニュース
Profusa files resale prospectus for up to 7,170,891 shares - scanx.trade
Profusa (NASDAQ: PFSA) resale 118,518 conversion shares after 1:25 split - Stock Titan
Profusa Announces 1-for-25 Reverse Stock Split Effective July 7, 2026 to Maintain Nasdaq Listing - Minichart
Profusa Implements 1-for-25 Reverse Stock Split on Nasdaq - TipRanks
Profusa (NASDAQ: PFSA) enacts 1-for-25 reverse stock split, cuts share count - Stock Titan
Why Did PFSA Stock Surge 150% Today? - Stocktwits
Profusa announces reverse stock split - Medical Buyer
PFSA Should I Buy - Intellectia AI
Profusa approves 1-for-25 reverse stock split; shares tumble - MSN
This Biotech Stock Crashed 28% Today After Announcing Second Reverse Share Split This Year - Asianet Newsable
11 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Profusa announces 1-for-25 reverse stock split effective July 7 - Investing.com
Profusa Announces 1-for-25 Reverse Stock Split Effective July 7, 2026 - Quiver Quantitative
Profusa to cut shares 25-to-1 before Nasdaq trading opens July 7 - Stock Titan
Enterprise value to revenue forward of Profusa, Inc. – NASDAQ:PFSA - TradingView
Price to book forward of Profusa, Inc. – NASDAQ:PFSA - TradingView
Price to earnings forward of Profusa, Inc. – NASDAQ:PFSA - TradingView
Profusa Company Profile & Introduction - Moomoo
At the 2026 annual meeting, Profusa Inc’s shareholders formally approved a series of key strategic initiatives. - Bitget
Which stocks are most active on Wednesday? - ChartMill
Profusa Shareholders Approve Reverse Split and Governance Changes - The Globe and Mail
Profusa shareholders approve acquisition, debt conversion proposals By Investing.com - Investing.com South Africa
Profusa (NASDAQ:PFSA) Advances Biosensing and Diagnostics Expansion - Kalkine Media
Profusa shareholders approve acquisition, debt conversion proposals - Investing.com
Profusa wins shareholder backing for PanOmics deal and Nasdaq push - Stock Titan
Profusa shareholders approve acquisition of PanOmics and reverse split - scanx.trade
Form 8K Profusa Inc For: 23 June By Investing.com - Investing.com South Africa
Profusa stockholders approve board proposals including director election and reverse split authorization - Investing.com UK
Profusa (PFSA) wins approval for reverse split, asset deal stock and larger equity plan - Stock Titan
Profusa submits response to European regulator for device approval - Investing.com UK
Profusa submits response to European regulator for device approval By Investing.com - Investing.com Canada
Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform - The Manila Times
Profusa Submits Response Package to GMED as Part of Ongoing Ce Mark Review Process for Lumee Oxygen Platform - marketscreener.com
Profusa submits response package to GMED for CE Mark review - scanx.trade
Profusa CEO urges shareholders to vote on Nasdaq listing proposals By Investing.com - Investing.com Nigeria
Profusa CEO urges shareholders to vote on Nasdaq listing proposals - Investing.com
Profusa Issues Letter to Shareholders Encouraging Shareholders to Vote FOR All Proposals at June 23, 2026 Annual Meeting - The Manila Times
Profusa Issues Letter to Shareholders Encouraging - GlobeNewswire
Profusa vote tied to Nasdaq listing efforts, PanOmics asset deal - Stock Titan
Profusa, Inc. Files 8-K: Advance Notice for Common Stock Purchase Under Equity Line Agreement with Ascent Partners, Nasdaq Listed (PFSA) - Minichart
Profusa (NASDAQ: PFSA) registers 179.3M shares; Ascent holds majority - Stock Titan
Profusa Taps Equity Line With Dilutive True-Up Mechanism - TipRanks
Profusa secures temporary equity purchase terms with Ascent under amended SPA - TradingView
Profusa (PFSA) adjusts Ascent equity line with caps, VWAP and true-up terms - Stock Titan
Profusa (PFSA) affiliates report 9.99% ownership; reorg adds Eagle Claw - Stock Titan
Profusa to acquire multi-omics platform, partners with Mayo Clinic - Investing.com
PFSA Stock Chart | PROFUSA INC (NASDAQ:PFSA) - ChartMill
PFSA Technical Analysis | Trend, Signals & Chart Patterns | PROFUSA INC (NASDAQ:PFSA) - ChartMill
Profusa Inc (PFSA) 財務データ
収益
当期純利益
現金流量
EPS
1.46%
0.43%
大文字化:
|
ボリューム (24 時間):